Autoimmune encephalitis: Epidemiology, pathophysiology and clinical spectrum (part 2)

Area of Science:

• Neurology
• Immunology
• Neuroscience

Background:

• Autoimmune encephalitis (AE) is an emerging group of severe autoimmune-inflammatory brain diseases.
• AE affects both white and grey matter, presenting complex neurological symptoms.
• Part 1 of this series covered AE epidemiology, pathophysiology, and clinical presentation.

Purpose of the Study:

• To introduce clinical criteria for diagnosing autoimmune encephalitis.
• To focus on diagnostic criteria for anti-N-methyl-D-aspartate (NMDA) receptor encephalitis.
• To facilitate timely immune treatment in suspected AE cases prior to antibody test results.

Main Methods:

• Review of clinical diagnostic criteria for autoimmune encephalitis.
• Focus on specific criteria for anti-NMDA receptor encephalitis.
• Discussion of diagnostic workup, differential diagnoses, and treatment strategies.

Main Results:

• Clinical criteria for AE diagnosis are presented.
• Specific diagnostic guidelines for anti-NMDA receptor encephalitis are introduced.
• The importance of early diagnosis for initiating immune treatment is highlighted.

Conclusions:

• Clinical criteria aid in the early diagnosis and management of autoimmune encephalitis.
• Prompt diagnosis of anti-NMDA receptor encephalitis is crucial for effective immune therapy.
• This approach supports timely treatment initiation in suspected AE cases.